HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
ABT
Abbott Laboratories
Healthcare Medical Devices · Illinois, USA · Reports in usd
Market Cap: $166.01B
Market Cap
$166.01B
Enterprise Val
$170.00B
P/E Ratio
25.45
P/B Ratio
3.15
Trailing PEG (1Y)
-0.31
As Of
Apr 15, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$52.77B
Gross Margin57.05%
Profit Margin57.05%
Return on Equity12.80%
Return on Assets7.76%
Current Ratio1.58
Debt/Equity0.25
LT Debt/Equity0.19
Revenue Per Share6.59

Income Statement

Dec 31, 2025
Revenue$11.46B
Cost of Revenue$4.92B
Gross Profit$6.54B
R&D$735.0M
SG&A$3.13B
Operating Expenses$4.29B
Operating Income$2.25B
Interest Expense$120.0M
Tax Expense$582.0M
Net Income$1.78B
EPS (Basic)$1.01
EPS (Diluted)$1.02
EBIT$2.48B
EBITDA$3.27B
Consolidated Income$1.78B
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$8.94B
Accounts Receivable$7.93B
Inventory$6.49B
Current Assets$26.00B
LT Investments$918.0M
Property, Plant & Equipment$11.82B
Intangibles$29.56B
Non-Current Assets$60.72B
Total Assets$86.71B
Accounts Payable$4.24B
Current Debt$3.03B
Current Liabilities$16.50B
LT Debt$9.90B
Non-Current Liabilities$17.45B
Total Liabilities$33.94B
Total Debt$12.93B
Retained Earnings$49.78B
Shareholder Equity$52.77B
Shares Outstanding1,738,871,947

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$3.32B
Investing Cash Flow-$913.0M
Financing Cash Flow-$1.40B
CapEx-$689.0M
Free Cash Flow$2.63B
Depreciation & Amort.$792.0M
Stock-Based Comp$113.0M
Acquisitions / Disposals-$20.0M
Investment Activity-$210.0M
Debt Issued/Repaid-$70.0M
Equity Issued/Repaid-$297.0M
Dividends Paid-$1.03B
Net Change in Cash$1.01B
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h